European Pharmaceutical Review

SEPTEMBER 26, 2022

AbbVie , an international R&D biopharmaceutical enterprise has celebrated its 20th anniversary by investing in extensive renovations at its manufacturing site in Cork, Ireland. The €60 million expansion will open 70 new jobs in sterile manufacturing, quality control and engineering in 2025.

Pharmaceutical Manufacturing

European Pharmaceutical Review

JULY 12, 2022

Microbes developing resistance to disinfectants is a major emerging problem in pharmaceutical manufacturing cleanrooms and, if left unchecked, could present a threat to drug quality and, therefore, human health. Microbial resistance is one of the factors responsible for such failings.

Pharmaceutical Manufacturing

pharmaphorum

OCTOBER 7, 2020

When I finally sought treatment in 2013, I learned how to turn my ADHD into a strength by better managing it. “Whether competing in the NFL, or in life, many of us feel that we can’t show weakness,” says Thomas. Unfortunately, this way of thinking has kept millions of adults and children from getting the treatment they need.

Pharmaceutical Manufacturing

Quality Matters

MAY 17, 2023

Paradigm Shift in Drug Development: Analytical Quality by Design and Analytical Procedure Life Cycle In today’s pharmaceutical manufacturing environment, companies face increasing pressure to respond to changing demands across the global medicines supply chain while still maintaining the quality of their drug products.

Drug Development

European Pharmaceutical Review

NOVEMBER 8, 2022

Pharmaceutical manufacturers have submitted Citizen Petitions raising safety or efficacy concerns about proposed competing generic and biosimilar products, and such submissions often delay FDA approval of the proposed products while the FDA resolves the pending petitions. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Biosimilars

Ramblings of a pharmacist

SEPTEMBER 26, 2023

First of all - the text of the law passed by Congress and signed into law on 11/27/2013 is available here, on page 562-595. Unfortunately, no one, from the manufacturers to the wholesalers to the dispensers to the FDA themselves has actually complied with the will of the 2013 Congress as written in the text of the DSCSA.

Communication

STAT

AUGUST 24, 2023

On July 1, drugmakers raised the wholesale price on more than 123 drugs in what’s the largest number of mid-year price hikes since 2013, according to data from drug pricing nonprofit 46brooklyn and the Elsevier Gold Standard Drug Database. Continue to STAT+ to read the full story…

Drug Pricing

pharmaphorum

JUNE 28, 2021

The lawsuits involving pharmaceutical manufacturers focus mainly on the “first wave” of the opioid crisis in the 1990s and 2000s, which the CDC says was driven by increased prescribing of painkillers.

Pharmaceutical Manufacturing

Pharmaceutical Commerce

JUNE 13, 2025

It is fair to say that the pharmacy benefit managers (PBMs) enabled it, but pharmaceutical manufacturers took advantage of it. PBMs contractually allowed pharmaceutical manufacturers to raise list prices within their annual contracts to a negotiated ceiling. It does indeed take two to tango.

Insurance Coverage and Processing